{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:57:43Z","timestamp":1788674263771,"version":"build-2803163510"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05634-6","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:43:02Z","timestamp":1767598982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Circulating Vesicular Biomarkers in Alzheimer\u2019s Disease: From Mechanistic Insights to Clinical Applications"],"prefix":"10.1007","volume":"63","author":[{"given":"Vinay","family":"Patil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavin","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Jyothi.S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8421-3630","authenticated-orcid":false,"given":"Priya","family":"Priyadarshini-Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethanney","family":"Janney-J","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurjant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaker","family":"Al-Hasnaawei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar-Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"5634_CR1","unstructured":"Organization WH. Global status report on the public health response to dementia. 2021."},{"key":"5634_CR2","doi-asserted-by":"crossref","unstructured":"Grinin L, Grinin A, Korotayev A (2024) Global aging, adaptation to it and future demographic transformations. Cybernetic Revolution and Global Aging: Humankind on the Way to Cybernetic Society, or the Next Hundred Years. Springer, pp 269\u2013327","DOI":"10.1007\/978-3-031-56764-3_7"},{"issue":"1","key":"5634_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3233\/JAD-240163","volume":"101","author":"A Lastuka","year":"2024","unstructured":"Lastuka A, Bliss E, Breshock MR, Iannucci VC, Sogge W, Taylor KV et al (2024) Societal costs of dementia: 204 countries, 2000\u20132019. J Alzheimers Dis 101(1):277\u201392","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"5634_CR4","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/jamaneurol.2021.2161","volume":"78","author":"S Hendriks","year":"2021","unstructured":"Hendriks S, Peetoom K, Bakker C, van der Flier WM, Papma JM, Koopmans R et al (2021) Global prevalence of young-onset dementia: a systematic review and meta-analysis. JAMA Neurol 78(9):1080\u20131090","journal-title":"JAMA Neurol"},{"issue":"1","key":"5634_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cger.2022.07.005","volume":"39","author":"RI Mehta","year":"2023","unstructured":"Mehta RI, Schneider JA (2023) Neuropathology of the common forms of dementia. Clin Geriatr Med 39(1):91\u2013107","journal-title":"Clin Geriatr Med"},{"issue":"4","key":"5634_CR6","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s10072-024-07871-4","volume":"46","author":"N Dong","year":"2025","unstructured":"Dong N, Ali-Khiavi P, Ghavamikia N, Pakmehr S, Sotoudegan F, Hjazi A et al (2025) Nanomedicine in the treatment of Alzheimer\u2019s disease: bypassing the blood-brain barrier with cutting-edge nanotechnology. Neurol Sci 46(4):1489\u20131507","journal-title":"Neurol Sci"},{"issue":"28","key":"5634_CR7","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1093\/eurheartj\/ehad293","volume":"44","author":"I Juul Rasmussen","year":"2023","unstructured":"Juul Rasmussen I, Frikke-Schmidt R (2023) Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia. Eur Heart J 44(28):2526\u20132543","journal-title":"Eur Heart J"},{"issue":"4","key":"5634_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10522-025-10254-7","volume":"26","author":"O Unal","year":"2025","unstructured":"Unal O, Akgun-Unal N, Baltaci AK (2025) Unveiling mysteries of aging: the potential of melatonin in preventing neurodegenerative diseases in older adults. Biogerontology 26(4):125","journal-title":"Biogerontology"},{"issue":"3","key":"5634_CR9","doi-asserted-by":"publisher","first-page":"794","DOI":"10.14336\/AD.2022.1123","volume":"14","author":"H Xu","year":"2023","unstructured":"Xu H, Liu YY, Li LS, Liu YS (2023) Sirtuins at the crossroads between mitochondrial quality control and neurodegenerative diseases: structure, regulation, modifications, and modulators. Aging Dis 14(3):794\u2013824","journal-title":"Aging Dis"},{"issue":"3","key":"5634_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70194","volume":"39","author":"N Ghavamikia","year":"2025","unstructured":"Ghavamikia N, Mehrnoosh F, Zare F, Ali-Khiavi P, Sinehsepehr A, Boushehri YG et al (2025) Mitochondrial quality control and melatonin: a strategy against myocardial injury. J Biochem Mol Toxicol 39(3):e70194","journal-title":"J Biochem Mol Toxicol"},{"key":"5634_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7040097","author":"KG Yiannopoulou","year":"2019","unstructured":"Yiannopoulou KG, Anastasiou AI, Zachariou V, Pelidou SH (2019) Reasons for failed trials of disease-modifying treatments for Alzheimer disease and their contribution in recent research. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines7040097","journal-title":"Biomedicines"},{"issue":"3","key":"5634_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.neumar.2025.100107","volume":"2","author":"J Braudeau","year":"2025","unstructured":"Braudeau J, Souchet B, Streel E (2025) Optimizing Alzheimer\u2019s diagnosis and precision medicine: a narrative review unlocking the potential of multiomics markers. NeuroMarkers 2(3):100107","journal-title":"NeuroMarkers"},{"issue":"1","key":"5634_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14397","volume":"21","author":"CE Teunissen","year":"2025","unstructured":"Teunissen CE, Kolster R, Triana-Baltzer G, Janelidze S, Zetterberg H, Kolb HC (2025) Plasma p-tau immunoassays in clinical research for Alzheimer\u2019s disease. Alzheimers Dement 21(1):e14397","journal-title":"Alzheimers Dement"},{"key":"5634_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clinbiochem.2019.04.015","volume":"72","author":"M Zv\u011b\u0159ov\u00e1","year":"2019","unstructured":"Zv\u011b\u0159ov\u00e1 M (2019) Clinical aspects of Alzheimer\u2019s disease. Clin Biochem 72:3\u20136","journal-title":"Clin Biochem"},{"issue":"7","key":"5634_CR15","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer\u2019s disease. Neurology 34(7):939\u2013944","journal-title":"Neurology"},{"key":"5634_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11020215","author":"DA McGrowder","year":"2021","unstructured":"McGrowder DA, Miller F, Vaz K, Nwokocha C, Wilson-Clarke C, Anderson-Cross M et al (2021) Cerebrospinal fluid biomarkers of Alzheimer\u2019s disease: current evidence and future perspectives. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci11020215","journal-title":"Brain Sci"},{"key":"5634_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137307","author":"S Holper","year":"2022","unstructured":"Holper S, Watson R, Yassi N (2022) Tau as a biomarker of neurodegeneration. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23137307","journal-title":"Int J Mol Sci"},{"key":"5634_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10040221","author":"E Del Prete","year":"2020","unstructured":"Del Prete E, Beatino MF, Campese N, Giampietri L, Siciliano G, Ceravolo R et al (2020) Fluid candidate biomarkers for Alzheimer\u2019s disease: a precision medicine approach. J Pers Med. https:\/\/doi.org\/10.3390\/jpm10040221","journal-title":"J Pers Med"},{"key":"5634_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157268","author":"VS Nunkoo","year":"2025","unstructured":"Nunkoo VS, Jurcau A, Les M, Cristian A, Militaru M, Marge C et al (2025) Circulating biomarkers for the early diagnosis of Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26157268","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5634_CR20","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/alz.12545","volume":"18","author":"C Delaby","year":"2022","unstructured":"Delaby C, Teunissen CE, Blennow K, Alcolea D, Arisi I, Amar EB et al (2022) Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer\u2019s disease: an international overview. Alzheimers Dement 18(10):1868\u201379","journal-title":"Alzheimers Dement"},{"issue":"8","key":"5634_CR21","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr.","year":"2024","unstructured":"Jack CR Jr., Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A et al (2024) Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement 20(8):5143\u201369","journal-title":"Alzheimers Dement"},{"issue":"1","key":"5634_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-00967-z","volume":"14","author":"C Delaby","year":"2022","unstructured":"Delaby C, Estell\u00e9s T, Zhu N, Arranz J, Barroeta I, Carmona-Iragui M et al (2022) The A\u03b21-42\/A\u03b21-40 ratio in CSF is more strongly associated to tau markers and clinical progression than A\u03b21-42 alone. Alzheimers Res Ther 14(1):20","journal-title":"Alzheimers Res Ther"},{"issue":"15","key":"5634_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157268","volume":"26","author":"VS Nunkoo","year":"2025","unstructured":"Nunkoo VS, Jurcau A, Les M, Cristian A, Militaru M, Marge C et al (2025) Circulating biomarkers for the early diagnosis of Alzheimer\u2019s disease. Int J Mol Sci 26(15):7268","journal-title":"Int J Mol Sci"},{"issue":"17","key":"5634_CR24","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","volume":"93","author":"SE Schindler","year":"2019","unstructured":"Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA et al (2019) High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis. Neurology 93(17):e1647\u2013e1659","journal-title":"Neurology"},{"issue":"1","key":"5634_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00911-7","volume":"13","author":"H Jang","year":"2021","unstructured":"Jang H, Kim JS, Lee HJ, Kim C-H, Na DL, Kim HJ et al (2021) Performance of the plasma A\u03b242\/A\u03b240 ratio, measured with a novel HPLC-MS\/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort. Alzheimers Res Ther 13(1):179","journal-title":"Alzheimers Res Ther"},{"key":"5634_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105405","author":"A Feizpour","year":"2024","unstructured":"Feizpour A, Doecke JD, Dor\u00e9 V, Krishnadas N, Huang K, Bourgeat P et al (2024) Detection and staging of Alzheimer\u2019s disease by plasma pTau217 on a high throughput immunoassay platform. eBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105405","journal-title":"eBioMedicine"},{"issue":"5","key":"5634_CR27","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","volume":"141","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G et al (2021) Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology. Acta Neuropathol 141(5):709\u2013724","journal-title":"Acta Neuropathol"},{"issue":"1","key":"5634_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01469-w","volume":"16","author":"Y Niimi","year":"2024","unstructured":"Niimi Y, Janelidze S, Sato K, Tomita N, Tsukamoto T, Kato T et al (2024) Combining plasma A\u03b2 and p-tau217 improves detection of brain amyloid in non-demented elderly. Alzheimers Res Ther 16(1):115","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"5634_CR29","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/s41591-025-03605-x","volume":"31","author":"G Grande","year":"2025","unstructured":"Grande G, Valletta M, Rizzuto D, Xia X, Qiu C, Orsini N et al (2025) Blood-based biomarkers of Alzheimer\u2019s disease and incident dementia in the community. Nat Med 31(6):2027\u20132035","journal-title":"Nat Med"},{"key":"5634_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105741","volume":"116","author":"A Gonz\u00e1lez-Escalante","year":"2025","unstructured":"Gonz\u00e1lez-Escalante A, Mil\u00e0-Alom\u00e0 M, Brum WS, Ashton NJ, Ortiz-Romero P, Shekari M et al (2025) A plasma biomarker panel for detecting early amyloid-\u03b2 accumulation and its changes in middle-aged cognitively unimpaired individuals at risk for Alzheimer\u2019s disease. EBioMedicine 116:105741","journal-title":"EBioMedicine"},{"key":"5634_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061630","author":"A Ahmad","year":"2023","unstructured":"Ahmad A, Imran M, Ahsan H (2023) Biomarkers as biomedical bioindicators: approaches and techniques for the detection, analysis, and validation of novel biomarkers of diseases. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15061630","journal-title":"Pharmaceutics"},{"issue":"3","key":"5634_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","volume":"243","author":"RM Califf","year":"2018","unstructured":"Califf RM (2018) Biomarker definitions and their applications. Exp Biol Med (Maywood) 243(3):213\u2013221","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"5634_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01314-6","volume":"15","author":"B Dubois","year":"2023","unstructured":"Dubois B, von Arnim CAF, Burnie N, Bozeat S, Cummings J (2023) Biomarkers in Alzheimer\u2019s disease: role in early and differential diagnosis and recognition of atypical variants. Alzheimers Res Ther 15(1):175","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"5634_CR34","doi-asserted-by":"publisher","first-page":"686","DOI":"10.14283\/jpad.2023.109","volume":"10","author":"M Kiraly","year":"2023","unstructured":"Kiraly M, Foss JF, Giordano T (2023) Neuroinflammation, its role in Alzheimer\u2019s disease and therapeutic strategies. J Prev Alzheimers Dis 10(4):686\u2013698","journal-title":"J Prev Alzheimers Dis"},{"key":"5634_CR35","doi-asserted-by":"crossref","unstructured":"Safiri S, Ghaffari Jolfayi A, Fazlollahi A, Morsali S, Sarkesh A, Daei Sorkhabi A et al (2024) Alzheimer\u2019s disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges. Front Med 11\u00a0","DOI":"10.3389\/fmed.2024.1474043"},{"key":"5634_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105776","volume":"170","author":"NH Mehta","year":"2022","unstructured":"Mehta NH, Suss RA, Dyke JP, Theise ND, Chiang GC, Strauss S et al (2022) Quantifying cerebrospinal fluid dynamics: a review of human neuroimaging contributions to CSF physiology and neurodegenerative disease. Neurobiol Dis 170:105776","journal-title":"Neurobiol Dis"},{"issue":"5","key":"5634_CR37","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.4269\/ajtmh.22-0699","volume":"108","author":"D Saylor","year":"2023","unstructured":"Saylor D, Elafros M, Bearden D, Dallah I, Mathews M, Muchanga G et al (2023) Patient, provider, and health systems factors leading to lumbar puncture nonperformance in Zambia: a qualitative investigation of the \u201ctap gap.\u201d Am J Trop Med Hyg 108(5):1052\u201362","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"5634_CR38","volume":"15","author":"I Suridjan","year":"2023","unstructured":"Suridjan I, van der Flier WM, Monsch AU, Burnie N, Baldor R, Sabbagh M et al (2023) Blood-based biomarkers in Alzheimer\u2019s disease: future directions for implementation. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring 15(4):e12508","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"7","key":"5634_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100204","volume":"12","author":"LA de Koning","year":"2025","unstructured":"de Koning LA, Vazquez-Matias DA, Beaino W, Vugts DJ, van Dongen GAMS, van der Flier WM et al (2025) Drug delivery strategies to cross the blood-brain barrier in Alzheimer\u2019s disease: a comprehensive review on three promising strategies. J Prev Alzheimers Dis 12(7):100204","journal-title":"J Prev Alzheimers Dis"},{"key":"5634_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.571083","volume":"11","author":"M Inyushin","year":"2020","unstructured":"Inyushin M, Zayas-Santiago A, Rojas L, Kucheryavykh L (2020) On the role of platelet-generated amyloid beta peptides in certain amyloidosis health complications. Front Immunol 11:571083","journal-title":"Front Immunol"},{"issue":"1","key":"5634_CR41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s40001-024-01915-3","volume":"29","author":"I Iqbal","year":"2024","unstructured":"Iqbal I, Saqib F, Mubarak Z, Latif MF, Wahid M, Nasir B et al (2024) Alzheimer\u2019s disease and drug delivery across the blood-brain barrier: approaches and challenges. Eur J Med Res 29(1):313","journal-title":"Eur J Med Res"},{"key":"5634_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/bios12090738","author":"SM Yoo","year":"2022","unstructured":"Yoo SM, Jeon YM, Heo SY (2022) Electrochemiluminescence systems for the detection of biomarkers: strategical and technological advances. Biosensors. https:\/\/doi.org\/10.3390\/bios12090738","journal-title":"Biosensors"},{"key":"5634_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2019.100005","volume":"1","author":"R Khoury","year":"2019","unstructured":"Khoury R, Ghossoub E (2019) Diagnostic biomarkers of Alzheimer\u2019s disease: a state-of-the-art review. Biomarkers in Neuropsychiatry 1:100005","journal-title":"Biomarkers in Neuropsychiatry"},{"issue":"1","key":"5634_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W (2023) Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther 8(1):248","journal-title":"Signal Transduct Target Ther"},{"key":"5634_CR45","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"C Cheignon","year":"2018","unstructured":"Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F (2018) Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol 14:450\u2013464","journal-title":"Redox Biol"},{"issue":"10","key":"5634_CR46","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH et al (2021) The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry 26(10):5481\u20135503","journal-title":"Mol Psychiatry"},{"issue":"1","key":"5634_CR47","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s43856-024-00690-w","volume":"4","author":"L Bl\u00f6meke","year":"2024","unstructured":"Bl\u00f6meke L, Rehn F, Pils M, Kraemer-Schulien V, Cousin A, Kutzsche J et al (2024) Blood-based quantification of A\u03b2 oligomers indicates impaired clearance from brain in ApoE \u03b54 positive subjects. Commun Med 4(1):262","journal-title":"Commun Med"},{"issue":"1","key":"5634_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01071-y","volume":"14","author":"HW Klafki","year":"2022","unstructured":"Klafki HW, Vogelgsang J, Manuilova E, Bauer C, Jethwa A, Esselmann H et al (2022) Diagnostic performance of automated plasma amyloid-\u03b2 assays combined with pre-analytical immunoprecipitation. Alzheimers Res Ther 14(1):127","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"5634_CR49","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/jamaneurol.2019.1632","volume":"76","author":"S Palmqvist","year":"2019","unstructured":"Palmqvist S, Janelidze S, Stomrud E, Zetterberg H, Karl J, Zink K et al (2019) Performance of fully automated plasma assays as screening tests for Alzheimer disease\u2013related \u03b2-amyloid status. JAMA Neurol 76(9):1060\u20131069","journal-title":"JAMA Neurol"},{"issue":"6","key":"5634_CR50","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/alz.12340","volume":"17","author":"A Avan","year":"2021","unstructured":"Avan A, Hachinski V (2021) Stroke and dementia, leading causes of neurological disability and death, potential for prevention. Alzheimers Dement 17(6):1072\u20131076","journal-title":"Alzheimers Dement"},{"key":"5634_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-025-03156-0","author":"S Hunter","year":"2025","unstructured":"Hunter S, Walsh S, Brayne C (2025) Key questions for the future of amyloid research in dementia: a framework for integrating complex datasets. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-025-03156-0","journal-title":"Mol Psychiatry"},{"key":"5634_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112841","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH (2022) Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232112841","journal-title":"Int J Mol Sci"},{"key":"5634_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00265","volume":"12","author":"P d\u2019Errico","year":"2020","unstructured":"d\u2019Errico P, Meyer-Luehmann M (2020) Mechanisms of pathogenic tau and A\u03b2 protein spreading in Alzheimer\u2019s disease. Front Aging Neurosci 12:265","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"5634_CR54","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/alz.12415","volume":"18","author":"MM Mielke","year":"2022","unstructured":"Mielke MM, Aakre JA, Algeciras-Schimnich A, Proctor NK, Machulda MM, Eichenlaub U et al (2022) Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline. Alzheimers Dement 18(4):602\u201311","journal-title":"Alzheimers Dement"},{"issue":"2","key":"5634_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.neumar.2025.100078","volume":"2","author":"H Li","year":"2025","unstructured":"Li H, Wang Z (2025) Blood biomarkers for clinical applications in Alzheimer\u2019s disease: a narrative review. NeuroMarkers 2(2):100078","journal-title":"NeuroMarkers"},{"key":"5634_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14070704","author":"H Colvee-Martin","year":"2024","unstructured":"Colvee-Martin H, Parra JR, Gonzalez GA, Barker W, Duara R (2024) Neuropathology, neuroimaging, and fluid biomarkers in Alzheimer\u2019s disease. Diagnostics Basel. https:\/\/doi.org\/10.3390\/diagnostics14070704","journal-title":"Diagnostics Basel"},{"issue":"9","key":"5634_CR57","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1002\/alz.13314","volume":"19","author":"C Vila\u2010Castelar","year":"2023","unstructured":"Vila\u2010Castelar C, Chen Y, Langella S, Lopera F, Zetterberg H, Hansson O et al (2023) Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer\u2019s disease. Alzheimers Dement 19(9):4127\u201338","journal-title":"Alzheimers Dement"},{"issue":"1","key":"5634_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00605-8","volume":"18","author":"F Gonzalez-Ortiz","year":"2023","unstructured":"Gonzalez-Ortiz F, Kac PR, Brum WS, Zetterberg H, Blennow K, Karikari TK (2023) Plasma phospho-tau in Alzheimer\u2019s disease: towards diagnostic and therapeutic trial applications. Mol Neurodegener 18(1):18","journal-title":"Mol Neurodegener"},{"key":"5634_CR59","first-page":"679","volume":"11","author":"AL Benedet","year":"2019","unstructured":"Benedet AL, Ashton NJ, Pascoal TA, Leuzy A, Mathotaarachchi S, Kang MS et al (2019) Plasma neurofilament light associates with Alzheimer\u2019s disease metabolic decline in amyloid\u2010positive individuals. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring 11:679\u2013689","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"5634_CR60","first-page":"1308","volume":"20","author":"E Kouchaki","year":"2021","unstructured":"Kouchaki E, Dashti F, Mohammad S, Mirazimi A, Alirezaei Z, Jafari SH et al (2021) Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis. EXCLI J 20:1308\u20131325","journal-title":"EXCLI J"},{"issue":"1","key":"5634_CR61","volume":"2024","author":"DN Abukuri","year":"2024","unstructured":"Abukuri DN (2024) Novel biomarkers for Alzheimer\u2019s disease: plasma neurofilament light and cerebrospinal fluid. Int J Alzheimers Dis 2024(1):6668159","journal-title":"Int J Alzheimers Dis"},{"issue":"1","key":"5634_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/brain\/awad267","volume":"147","author":"Y Jung","year":"2024","unstructured":"Jung Y, Damoiseaux JS (2024) The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer\u2019s disease. Brain 147(1):12\u201325","journal-title":"Brain"},{"issue":"9","key":"5634_CR63","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1002\/alz.13314","volume":"19","author":"C Vila-Castelar","year":"2023","unstructured":"Vila-Castelar C, Chen Y, Langella S, Lopera F, Zetterberg H, Hansson O et al (2023) Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer\u2019s disease. Alzheimers Dement 19(9):4127\u201338","journal-title":"Alzheimers Dement"},{"issue":"3","key":"5634_CR64","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/ana.27285","volume":"98","author":"M Mil\u00e0-Alom\u00e0","year":"2025","unstructured":"Mil\u00e0-Alom\u00e0 M, Tosun D, Schindler SE, Hausle I, Petersen KK, Li Y et al (2025) <article-title update=\"added\"> Timing of changes in Alzheimer\u2019s disease plasma biomarkers as assessed by amyloid and tau <scp>PET<\/scp> clocks. Ann Neurol 98(3):508\u201323","journal-title":"Ann Neurol"},{"key":"5634_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05219-3","author":"EMS Bandara","year":"2025","unstructured":"Bandara EMS, Asih PR, Pedrini S, Hone E, Fernando WMADB, Martins RN (2025) The role of glial fibrillary acidic protein in the neuropathology of Alzheimer\u2019s disease and its potential as a blood biomarker for early diagnosis and progression. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-05219-3","journal-title":"Mol Neurobiol"},{"key":"5634_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2025.100724","author":"VR Varma","year":"2025","unstructured":"Varma VR, An Y, Kac PR, Bilgel M, Moghekar A, Loeffler T et al (2025) Longitudinal progression of blood biomarkers reveals a key role of reactive astrocytosis in preclinical Alzheimer\u2019s disease. Med. https:\/\/doi.org\/10.1016\/j.medj.2025.100724","journal-title":"Med"},{"issue":"11","key":"5634_CR67","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1093\/brain\/awab223","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, Janelidze S, Smith R, Mattsson-Carlgren N, Palmqvist S, Teunissen CE et al (2021) Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease. Brain 144(11):3505\u20133516","journal-title":"Brain"},{"issue":"1","key":"5634_CR68","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12974-020-01878-2","volume":"17","author":"J Yang","year":"2020","unstructured":"Yang J, Fu Z, Zhang X, Xiong M, Meng L, Zhang Z (2020) TREM2 ectodomain and its soluble form in Alzheimer\u2019s disease. J Neuroinflammation 17(1):204","journal-title":"J Neuroinflammation"},{"issue":"3","key":"5634_CR69","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neurol.2022.09.003","volume":"179","author":"C Delaby","year":"2023","unstructured":"Delaby C, Hirtz C, Lehmann S (2023) Overview of the blood biomarkers in Alzheimer\u2019s disease: promises and challenges. Rev Neurol (Paris) 179(3):161\u2013172","journal-title":"Rev Neurol (Paris)"},{"key":"5634_CR70","doi-asserted-by":"publisher","unstructured":"Boakye PA, Tang SJ, Smith PA et al (2021) Mediators of neuropathic pain; focus on spinal microglia, CSF\u20111, BDNF, CCL21, TNF\u2011\u03b1, Wnt ligands, and interleukin 1\u03b2. Front Pain Res 2:698157. https:\/\/doi.org\/10.3389\/fpain.2021.69815","DOI":"10.3389\/fpain.2021.69815"},{"key":"5634_CR71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bbi.2020.12.001","volume":"95","author":"JZK Caldwell","year":"2021","unstructured":"Caldwell JZK, Kinney JW, Ritter A, Salazar A, Wong CG, Cordes D et al (2021) Inflammatory cytokine levels implicated in Alzheimer\u2019s disease moderate the effects of sex on verbal memory performance. Brain Behav Immun 95:27\u201335","journal-title":"Brain Behav Immun"},{"key":"5634_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13040923","author":"OM Al-Sanabra","year":"2025","unstructured":"Al-Sanabra OM, Abu-Qatouseh LF, Ahmad MIA, Al-Khreisat MJ, Alsaleh MM (2025) Diminishing hepcidin via reducing IL-6\/STAT3 pathway by utilizing ferulic acid: an in vitro study. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13040923","journal-title":"Biomedicines"},{"key":"5634_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.670115","volume":"13","author":"CS Liang","year":"2021","unstructured":"Liang CS, Tsai CL, Lin GY, Lee JT, Lin YK, Chu CS et al (2021) Better identification of cognitive decline with interleukin-2 than with amyloid and tau protein biomarkers in amnestic mild cognitive impairment. Front Aging Neurosci 13:670115","journal-title":"Front Aging Neurosci"},{"key":"5634_CR74","doi-asserted-by":"crossref","unstructured":"Tosun D, Demir Z, Veitch DP, Weintraub D, Aisen P, Jack CR Jr et al (2022) Contribution of Alzheimer\u2019s biomarkers and risk factors to cognitive impairment and decline across the Alzheimer\u2019s disease continuum. Alzheimer\u2019s & Dementia 18(7):1370\u20131382","DOI":"10.1002\/alz.12480"},{"key":"5634_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.117905","volume":"184","author":"M Rob","year":"2025","unstructured":"Rob M, Yousef M, Lakshmanan AP, Mahboob A, Terranegra A, Chaari A (2025) Microbial signatures and therapeutic strategies in neurodegenerative diseases. Biomed Pharmacother 184:117905","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"5634_CR76","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K (2019) Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA Neurol 76(7):791\u2013799","journal-title":"JAMA Neurol"},{"issue":"12","key":"5634_CR77","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1093\/brain\/awaa342","volume":"143","author":"AL Benedet","year":"2020","unstructured":"Benedet AL, Leuzy A, Pascoal TA, Ashton NJ, Mathotaarachchi S, Savard M et al (2020) Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer\u2019s disease. Brain 143(12):3793\u20133804","journal-title":"Brain"},{"issue":"1","key":"5634_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00804-9","volume":"13","author":"C Cicognola","year":"2021","unstructured":"Cicognola C, Janelidze S, Hertze J, Zetterberg H, Blennow K, Mattsson-Carlgren N et al (2021) Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment. Alzheimers Res Ther 13(1):68","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"5634_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92101-6","volume":"11","author":"S-H Park","year":"2021","unstructured":"Park S-H, Lee E-H, Kim H-J, Jo S, Lee S, Seo SW et al (2021) The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer\u2019s disease. Sci Rep 11(1):13050","journal-title":"Sci Rep"},{"issue":"3","key":"5634_CR80","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/neurolint15030053","volume":"15","author":"E \u0160pani\u0107 Popova\u010dki","year":"2023","unstructured":"\u0160pani\u0107 Popova\u010dki E, Babi\u0107 Leko M, Langer Horvat L, Brgi\u0107 K, Vogrinc \u017d, Boban M et al (2023) Soluble TREM2 concentrations in the cerebrospinal fluid correlate with the severity of neurofibrillary degeneration, cognitive impairment, and inflammasome activation in Alzheimer\u2019s disease. Neurol Int 15(3):842\u201356","journal-title":"Neurol Int"},{"issue":"1","key":"5634_CR81","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12974-017-0893-7","volume":"14","author":"M Querol-Vilaseca","year":"2017","unstructured":"Querol-Vilaseca M, Colom-Cadena M, Pegueroles J, San Mart\u00edn-Paniello C, Clarimon J, Belbin O et al (2017) YKL-40 (chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer\u2019s disease and other tauopathies. J Neuroinflammation 14(1):118","journal-title":"J Neuroinflammation"},{"key":"5634_CR82","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax3519","author":"BV Lananna","year":"2020","unstructured":"Lananna BV, McKee CA, King MW, Del-Aguila JL, Dimitry JM, Farias FHG et al (2020) Chi3l1\/YKL-40 is controlled by the astrocyte circadian clock and regulates neuroinflammation and Alzheimer\u2019s disease pathogenesis. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aax3519","journal-title":"Sci Transl Med"},{"issue":"1","key":"5634_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19807-y","volume":"8","author":"W-J Lee","year":"2018","unstructured":"Lee W-J, Liao Y-C, Wang Y-F, Lin IF, Wang S-J, Fuh J-L (2018) Plasma MCP-1 and cognitive decline in patients with Alzheimer\u2019s disease and mild cognitive impairment: a two-year follow-up study. Sci Rep 8(1):1280","journal-title":"Sci Rep"},{"issue":"1","key":"5634_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01254-1","volume":"15","author":"F Zhou","year":"2023","unstructured":"Zhou F, Sun Y, Xie X, Zhao Y (2023) Blood and CSF chemokines in Alzheimer\u2019s disease and mild cognitive impairment: a systematic review and meta-analysis. Alzheimers Res Ther 15(1):107","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"5634_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103751","volume":"28","author":"G Astarita","year":"2023","unstructured":"Astarita G, Kelly RS, Lasky-Su J (2023) Metabolomics and lipidomics strategies in modern drug discovery and development. Drug Discov Today 28(10):103751","journal-title":"Drug Discov Today"},{"issue":"1","key":"5634_CR86","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/alz.12369","volume":"18","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhou X, Ip FC, Chan P, Chen Y, Lai NCH et al (2022) Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer\u2019s disease screening and staging. Alzheimers Dement 18(1):88\u2013102","journal-title":"Alzheimers Dement"},{"key":"5634_CR87","doi-asserted-by":"publisher","unstructured":"Lacar BS, Ferdosi A, Alavi A. Stukalov GR, Venkataraman M, de Geus M, Dodge H, Wu CY, Kivisakk P, Das S, Hyman H, Batzoglou S, Arnold S, Siddiqui AE et al (2024) Identification of novel biomarkers for Alzheimer\u2019s disease and related dementias using unbiased plasma proteomics. bioRxiv. https:\/\/doi.org\/10.1101\/2024.01.05.574446","DOI":"10.1101\/2024.01.05.574446"},{"key":"5634_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814164","author":"VS Dhillon","year":"2023","unstructured":"Dhillon VS, Thomas P, Lee SL, Deo P, Fenech M (2023) Red blood cell fatty acid profiles are significantly altered in South Australian mild cognitive impairment and Alzheimer\u2019s disease cases compared to matched controls. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241814164","journal-title":"Int J Mol Sci"},{"key":"5634_CR89","doi-asserted-by":"publisher","unstructured":"Yin F (2023) Lipid metabolism and Alzheimer\u2019s disease: Clinical evidence, mechanistic link and therapeutic promise. FEBS J 290(6):1420\u20131453. https:\/\/doi.org\/10.1111\/febs.16344","DOI":"10.1111\/febs.16344"},{"issue":"2","key":"5634_CR90","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00018-017-2591-0","volume":"75","author":"M Olejniczak","year":"2018","unstructured":"Olejniczak M, Kotowska-Zimmer A, Krzyzosiak W (2018) Stress-induced changes in miRNA biogenesis and functioning. Cell Mol Life Sci 75(2):177\u2013191","journal-title":"Cell Mol Life Sci"},{"key":"5634_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20163979","author":"S Silvestro","year":"2019","unstructured":"Silvestro S, Bramanti P, Mazzon E (2019) Role of miRNAs in Alzheimer\u2019s disease and possible fields of application. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20163979","journal-title":"Int J Mol Sci"},{"key":"5634_CR92","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cbpa.2019.01.024","volume":"51","author":"Q Yao","year":"2019","unstructured":"Yao Q, Chen Y, Zhou X (2019) The roles of microRNAs in epigenetic regulation. Curr Opin Chem Biol 51:11\u201317","journal-title":"Curr Opin Chem Biol"},{"key":"5634_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.785433","volume":"15","author":"Y Liang","year":"2021","unstructured":"Liang Y, Wang L (2021) Inflamma-microRNAs in Alzheimer\u2019s disease: from disease pathogenesis to therapeutic potentials. Front Cell Neurosci 15:785433","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"5634_CR94","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3233\/JAD-160468","volume":"55","author":"B Xie","year":"2017","unstructured":"Xie B, Liu Z, Jiang L, Liu W, Song M, Zhang Q et al (2017) Increased serum miR-206 level predicts conversion from amnestic mild cognitive impairment to Alzheimer\u2019s disease: a\u00a05-year follow-up study. J Alzheimers Dis 55(2):509\u201320","journal-title":"J Alzheimers Dis"},{"key":"5634_CR95","doi-asserted-by":"publisher","unstructured":"Ansari A, Maffioletti E, Milanesi E, Marizzoni M, Frisoni GB, Blin O, Richardson JC, Bordet R, Forloni G, Gennarelli M, Bocchio\u2011Chiavetto L et al (2019) miR\u2011146a and miR\u2011181a are involved in the progression of mild cognitive impairment to alzheimer\u2019s disease. Neurobiol Aging 82:102\u2013109. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.06.005","DOI":"10.1016\/j.neurobiolaging.2019.06.005"},{"issue":"11","key":"5634_CR96","doi-asserted-by":"publisher","first-page":"7479","DOI":"10.1002\/alz.14157","volume":"20","author":"DM Kr\u00fcger","year":"2024","unstructured":"Kr\u00fcger DM, Pena-Centeno T, Liu S, Park T, Kaurani L, Pradhan R et al (2024) The plasma miRNAome in ADNI: signatures to aid the detection of at-risk individuals. Alzheimer\u2019s & Dementia 20(11):7479\u20137494","journal-title":"Alzheimer's & Dementia"},{"key":"5634_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11121275","author":"A Turk","year":"2021","unstructured":"Turk A, Kunej T, Peterlin B (2021) Microrna-target interaction regulatory network in Alzheimer\u2019s disease. J Pers Med. https:\/\/doi.org\/10.3390\/jpm11121275","journal-title":"J Pers Med"},{"key":"5634_CR98","volume":"34","author":"RK Yashooa","year":"2022","unstructured":"Yashooa RK, Nabi AQ (2022) The miR-146a-5p and miR-125b-5p levels as biomarkers for early prediction of Alzheimer\u2019s disease. Hum Genet 34:201129","journal-title":"Hum Genet"},{"key":"5634_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.641080","volume":"13","author":"M Samadian","year":"2021","unstructured":"Samadian M, Gholipour M, Hajiesmaeili M, Taheri M, Ghafouri-Fard S (2021) The eminent role of micrornas in the pathogenesis of Alzheimer\u2019s disease. Front Aging Neurosci 13:641080","journal-title":"Front Aging Neurosci"},{"key":"5634_CR100","doi-asserted-by":"publisher","unstructured":"Wei W, Wang ZY, Ma LN, Zhang TT, Cao Y, Li H (2020) MicroRNAs in Alzheimer\u2019s disease: function and potential applications as diagnostic biomarkers. Front Mol Neurosci 13:160. https:\/\/doi.org\/10.3389\/fnmol.2020.00160","DOI":"10.3389\/fnmol.2020.00160"},{"issue":"5","key":"5634_CR101","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s13346-021-01026-0","volume":"12","author":"GG Shetgaonkar","year":"2022","unstructured":"Shetgaonkar GG, Marques SM, Dcruz CEM, Vibhavari RJA, Kumar L, Shirodkar RK (2022) Exosomes as cell-derivative carriers in the diagnosis and treatment of central nervous system diseases. Drug Deliv Transl Res 12(5):1047\u20131079","journal-title":"Drug Deliv Transl Res"},{"issue":"5","key":"5634_CR102","doi-asserted-by":"publisher","first-page":"930","DOI":"10.4103\/1673-5374.232490","volume":"13","author":"ZY Cai","year":"2018","unstructured":"Cai ZY, Xiao M, Quazi SH, Ke ZY (2018) Exosomes: a novel therapeutic target for Alzheimer\u2019s disease? Neural Regen Res 13(5):930\u2013935","journal-title":"Neural Regen Res"},{"key":"5634_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.101771","volume":"49","author":"VP Chavda","year":"2023","unstructured":"Chavda VP, Pandya A, Kumar L, Raval N, Vora LK, Pulakkat S et al (2023) Exosome nanovesicles: a potential carrier for therapeutic delivery. Nano Today 49:101771","journal-title":"Nano Today"},{"issue":"1","key":"5634_CR104","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03807-2","volume":"16","author":"M Nourizadeh","year":"2025","unstructured":"Nourizadeh M, Mounesyar SM, Movahhed MS, Alipour K, Zekavatbakhsh R, Hoseinzadeh M et al (2025) Current strategies and novel immunotherapeutic approaches for overcoming immune resistance in glioblastoma. Discov Oncol 16(1):1952","journal-title":"Discov Oncol"},{"key":"5634_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1254834","volume":"10","author":"A Manolopoulos","year":"2023","unstructured":"Manolopoulos A, Delgado-Peraza F, Mustapic M, Pucha KA, Nogueras-Ortiz C, Daskalopoulos A et al (2023) Comparative assessment of Alzheimer\u2019s disease-related biomarkers in plasma and neuron-derived extracellular vesicles: a nested case-control study. Front Mol Biosci 10:1254834","journal-title":"Front Mol Biosci"},{"key":"5634_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.104988","volume":"145","author":"M Yan","year":"2021","unstructured":"Yan M, Zheng T (2021) Role of the endolysosomal pathway and exosome release in tau propagation. Neurochem Int 145:104988","journal-title":"Neurochem Int"},{"key":"5634_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2023.137532","volume":"817","author":"A Gholami","year":"2023","unstructured":"Gholami A (2023) Alzheimer\u2019s disease: the role of proteins in formation, mechanisms, and new therapeutic approaches. Neurosci Lett 817:137532","journal-title":"Neurosci Lett"},{"key":"5634_CR108","doi-asserted-by":"publisher","unstructured":"Kirouac L, Rajic AJ, Cribbs DH, Padmanabhan J et al (2017) Activation of Ras-ERK signaling and GSK-3 by amyloid precursor protein and amyloid beta facilitates neurodegeneration in alzheimer\u2019s disease. eNeuro 4(2). https:\/\/doi.org\/10.1523\/ENEURO.0149-16.2017","DOI":"10.1523\/ENEURO.0149-16.2017"},{"issue":"11","key":"5634_CR109","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.4103\/1673-5374.335832","volume":"17","author":"WL Liu","year":"2022","unstructured":"Liu WL, Lin HW, Lin MR, Yu Y, Liu HH, Dai YL et al (2022) Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer\u2019s disease: a meta-analysis and systematic review. Neural Regen Res 17(11):2381\u20132390","journal-title":"Neural Regen Res"},{"issue":"7","key":"5634_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100193","volume":"12","author":"W Pan","year":"2025","unstructured":"Pan W, Teng Y, Han X, Liu S, Pang X, Wang L et al (2025) Value of blood neural cell-derived small extracellular vesicles in the diagnosis and prediction of Alzheimer\u2019s disease: a systematic review. J Prev Alzheimers Dis 12(7):100193","journal-title":"J Prev Alzheimers Dis"},{"issue":"4","key":"5634_CR111","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4103\/NRR.NRR-D-24-01016","volume":"21","author":"S Zhang","year":"2026","unstructured":"Zhang S, Li J, Hu X, Liu H, Yu Q, Kuang G et al (2026) Brain-derived extracellular vesicles: a promising avenue for Parkinson\u2019s disease pathogenesis, diagnosis, and treatment. Neural Regen Res 21(4):1447\u20131467","journal-title":"Neural Regen Res"},{"issue":"226","key":"5634_CR112","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007901","volume":"6","author":"AM Fagan","year":"2014","unstructured":"Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL et al (2014) Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer\u2019s disease. Sci Transl Med 6(226):226ra30","journal-title":"Sci Transl Med"},{"issue":"1","key":"5634_CR113","doi-asserted-by":"publisher","first-page":"133","DOI":"10.20517\/evcna.2023.13","volume":"4","author":"E Eitan","year":"2023","unstructured":"Eitan E, Thornton-Wells T, Elgart K, Erden E, Gershun E, Levine A et al (2023) Synaptic proteins in neuron-derived extracellular vesicles as biomarkers for Alzheimer\u2019s disease: novel methodology and clinical proof of concept. Extracell Vesicles Circ Nucleic Acids 4(1):133\u2013150","journal-title":"Extracell Vesicles Circ Nucleic Acids"},{"issue":"1","key":"5634_CR114","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13195-023-01303-9","volume":"15","author":"F Delgado-Peraza","year":"2023","unstructured":"Delgado-Peraza F, Nogueras-Ortiz C, Simonsen AH, Knight DLD, Yao PJ, Goetzl EJ et al (2023) Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer\u2019s disease. Alzheimers Res Ther 15(1):156","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"5634_CR115","doi-asserted-by":"publisher","first-page":"16122","DOI":"10.18632\/oncotarget.15109","volume":"8","author":"S Nagaraj","year":"2017","unstructured":"Nagaraj S, Laskowska-Kaszub K, D\u0119bski KJ, Wojsiat J, D\u0105browski M, Gabryelewicz T et al (2017) Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer\u2019s disease patients from non-demented subjects. Oncotarget 8(10):16122\u201316143","journal-title":"Oncotarget"},{"key":"5634_CR116","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-021-02323-y","author":"Z Dong","year":"2021","unstructured":"Dong Z, Gu H, Guo Q, Liang S, Xue J, Yao F et al (2021) Profiling of serum exosome mirna reveals the potential of a MiRNA panel as diagnostic biomarker for Alzheimer\u2019s disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-021-02323-y","journal-title":"Mol Neurobiol"},{"key":"5634_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12100949","author":"M Fran\u00e7ois","year":"2022","unstructured":"Fran\u00e7ois M, Karpe AV, Liu JW, Beale DJ, Hor M, Hecker J et al (2022) Multi-omics, an integrated approach to identify novel blood biomarkers of Alzheimer\u2019s disease. Metabolites. https:\/\/doi.org\/10.3390\/metabo12100949","journal-title":"Metabolites"},{"issue":"1","key":"5634_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71097-9","volume":"14","author":"SM Tokuoka","year":"2024","unstructured":"Tokuoka SM, Hamano F, Kobayashi A, Adachi S, Andou T, Natsume T et al (2024) Plasma proteomics and lipidomics facilitate elucidation of the link between Alzheimer\u2019s disease development and vessel wall fragility. Sci Rep 14(1):19901","journal-title":"Sci Rep"},{"issue":"50","key":"5634_CR119","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2213157119","volume":"119","author":"D Shea","year":"2022","unstructured":"Shea D, Colasurdo E, Smith A, Paschall C, Jayadev S, Keene CD et al (2022) SOBA: development and testing of a soluble oligomer binding assay for detection of amyloidogenic toxic oligomers. Proc Natl Acad Sci U S A 119(50):e2213157119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5634_CR120","doi-asserted-by":"publisher","first-page":"7946","DOI":"10.1038\/s41598-024-57107-w","volume":"14","author":"A Chen","year":"2024","unstructured":"Chen A, Shea D, Daggett V (2024) Performance of SOBA-AD blood test in discriminating Alzheimer\u2019s disease patients from cognitively unimpaired controls in two independent cohorts. Sci Rep 14(1):7946","journal-title":"Sci Rep"},{"issue":"10","key":"5634_CR121","doi-asserted-by":"publisher","first-page":"6669","DOI":"10.1002\/alz.13924","volume":"20","author":"T Hou","year":"2024","unstructured":"Hou T, Liu K, Fa W, Liu C, Zhu M, Liang X et al (2024) Association of polygenic risk scores with Alzheimer\u2019s disease and plasma biomarkers among Chinese older adults: a community-based study. Alzheimers Dement 20(10):6669\u20136681","journal-title":"Alzheimers Dement"},{"issue":"2","key":"5634_CR122","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/brain\/awac128","volume":"146","author":"J Stevenson-Hoare","year":"2023","unstructured":"Stevenson-Hoare J, Heslegrave A, Leonenko G, Fathalla D, Bellou E, Luckcuck L et al (2023) Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer\u2019s disease. Brain 146(2):690\u2013699","journal-title":"Brain"},{"issue":"3","key":"5634_CR123","doi-asserted-by":"publisher","first-page":"371","DOI":"10.14283\/jpad.2021.23","volume":"8","author":"AP Porsteinsson","year":"2021","unstructured":"Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I (2021) Diagnosis of early Alzheimer\u2019s disease: clinical practice in 2021. J Prev Alzheimers Dis 8(3):371\u2013386","journal-title":"J Prev Alzheimers Dis"},{"key":"5634_CR124","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.dadm.2019.02.002","volume":"11","author":"M R\u00f3zga","year":"2019","unstructured":"R\u00f3zga M, Bittner T, Batrla R, Karl J (2019) Preanalytical sample handling recommendations for Alzheimer\u2019s disease plasma biomarkers. Alzheimers Dement (Amst) 11:291\u2013300","journal-title":"Alzheimers Dement (Amst)"},{"issue":"11","key":"5634_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70828","volume":"21","author":"S Pahlke","year":"2025","unstructured":"Pahlke S, Kahale LA, Mahinrad S, Sousa-Pinto B, Vieira RJ, McAteer MB et al (2025) Blood-based biomarkers for detecting Alzheimer\u2019s disease pathology in cognitively impaired individuals within specialized care settings: a systematic review and meta-analysis. Alzheimer\u2019s & Dementia 21(11):e70828","journal-title":"Alzheimer's & Dementia"},{"issue":"1","key":"5634_CR126","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1021\/acs.analchem.4c04188","volume":"97","author":"D B\u00f6ken","year":"2025","unstructured":"B\u00f6ken D, Xia Z, Lam JYL, Fertan E, Wu Y, English EA et al (2025) Ultrasensitive protein aggregate quantification assays for neurodegenerative diseases on the simoa platform. Anal Chem 97(1):290\u2013299","journal-title":"Anal Chem"},{"issue":"1","key":"5634_CR127","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3233\/ADR-230029","volume":"7","author":"MV Pais","year":"2023","unstructured":"Pais MV, Forlenza OV, Diniz BS (2023) Plasma biomarkers of Alzheimer\u2019s disease: a review of available assays, recent developments, and implications for clinical practice. J Alzheimers Dis Rep 7(1):355\u2013380","journal-title":"J Alzheimers Dis Rep"},{"issue":"3","key":"5634_CR128","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/alz.12697","volume":"19","author":"S Zicha","year":"2023","unstructured":"Zicha S, Bateman RJ, Shaw LM, Zetterberg H, Bannon AW, Horton WA et al (2023) Comparative analytical performance of multiple plasma A\u03b242 and A\u03b240 assays and their ability to predict positron emission tomography amyloid positivity. Alzheimers Dement 19(3):956\u2013966","journal-title":"Alzheimers Dement"},{"issue":"5","key":"5634_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100150","volume":"12","author":"GD Rabinovici","year":"2025","unstructured":"Rabinovici GD, Selkoe DJ, Schindler SE, Aisen P, Apostolova LG, Atri A et al (2025) Donanemab: appropriate use recommendations. J Prev Alzheimers Dis 12(5):100150","journal-title":"J Prev Alzheimers Dis"},{"issue":"3","key":"5634_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12465","volume":"15","author":"C Giangrande","year":"2023","unstructured":"Giangrande C, Delatour V, Andreasson U, Blennow K, Gobom J, Zetterberg H (2023) Harmonization and standardization of biofluid-based biomarker measurements for AT(N) classification in Alzheimer\u2019s disease. Alzheimers Dement (Amst) 15(3):e12465","journal-title":"Alzheimers Dement (Amst)"},{"issue":"18","key":"5634_CR131","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1016\/j.neuron.2023.05.017","volume":"111","author":"H Hampel","year":"2023","unstructured":"Hampel H, Hu Y, Cummings J, Mattke S, Iwatsubo T, Nakamura A et al (2023) Blood-based biomarkers for Alzheimer\u2019s disease: current state and future use in a transformed global healthcare landscape. Neuron 111(18):2781\u20132799","journal-title":"Neuron"},{"issue":"4","key":"5634_CR132","doi-asserted-by":"publisher","first-page":"802","DOI":"10.14283\/jpad.2024.122","volume":"11","author":"RA Sperling","year":"2024","unstructured":"Sperling RA, Donohue MC, Rissman RA, Johnson KA, Rentz DM, Grill JD et al (2024) Amyloid and tau prediction of cognitive and functional decline in unimpaired older individuals: longitudinal data from the A4 and LEARN studies. J Prev Alzheimers Dis 11(4):802\u2013813","journal-title":"J Prev Alzheimers Dis"},{"issue":"3","key":"5634_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2024.100054","volume":"12","author":"C Zhang","year":"2025","unstructured":"Zhang C, Li B, Ng KP, Tai Y, Tai Y, Song X et al (2025) Plasma neurofilament light mediates the effects of Apolipoprotein E on brain atrophy and cognitive decline in the comorbid Alzheimer\u2019s disease and cerebral small vessel disease. J Prev Alzheimers Dis 12(3):100054","journal-title":"J Prev Alzheimers Dis"},{"key":"5634_CR134","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2020.05.011","volume":"94","author":"MA Sugarman","year":"2020","unstructured":"Sugarman MA, Zetterberg H, Blennow K, Tripodis Y, McKee AC, Stein TD et al (2020) A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer\u2019s disease. Neurobiol Aging 94:60\u201370","journal-title":"Neurobiol Aging"},{"issue":"1","key":"5634_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01712-y","volume":"17","author":"B Jiao","year":"2025","unstructured":"Jiao B, Ouyang Z, Liu Y, Zhang C, Xu T, Yang Q et al (2025) Evaluating the diagnostic performance of six plasma biomarkers for Alzheimer\u2019s disease and other neurodegenerative dementias in a large Chinese cohort. Alzheimers Res Ther 17(1):71","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"5634_CR136","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1038\/s41467-021-23746-0","volume":"12","author":"NC Cullen","year":"2021","unstructured":"Cullen NC, Leuzy A, Janelidze S, Palmqvist S, Svenningsson AL, Stomrud E et al (2021) Plasma biomarkers of Alzheimer\u2019s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations. Nat Commun 12(1):3555","journal-title":"Nat Commun"},{"key":"5634_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178564","author":"V Pacoova Dal Maschio","year":"2025","unstructured":"Pacoova Dal Maschio V, Roveta F, Bonino L, Boschi S, Rainero I, Rubino E (2025) The role of blood-based biomarkers in transforming Alzheimer\u2019s disease research and clinical management: a review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26178564","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5634_CR138","first-page":"143","volume":"35","author":"DA Armbruster","year":"2014","unstructured":"Armbruster DA, Overcash DR, Reyes J (2014) Clinical chemistry laboratory automation in the 21st century - Amat Victoria curam (victory loves careful preparation). Clin Biochem Rev 35(3):143\u2013153","journal-title":"Clin Biochem Rev"},{"key":"5634_CR139","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10030414","author":"A Menzel","year":"2021","unstructured":"Menzel A, Samouda H, Dohet F, Loap S, Ellulu MS, Bohn T (2021) Common and novel markers for measuring inflammation and oxidative stress ex vivo in research and clinical practice-which to use regarding disease outcomes? Antioxidants. https:\/\/doi.org\/10.3390\/antiox10030414","journal-title":"Antioxidants"},{"issue":"6","key":"5634_CR140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252547","volume":"16","author":"X Yan","year":"2021","unstructured":"Yan X, Imano N, Tamaki K, Sano M, Shinmura K (2021) The effect of caloric restriction on the increase in senescence-associated T cells and metabolic disorders in aged mice. PLoS One 16(6):e0252547","journal-title":"PLoS One"},{"issue":"1","key":"5634_CR141","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/joim.20098","volume":"298","author":"NR Fowler","year":"2025","unstructured":"Fowler NR, Partrick KA, Taylor J, Hornbecker M, Kelleher K, Boustani M et al (2025) Implementing early detection of cognitive impairment in primary care to improve care for older adults. J Intern Med 298(1):31\u201345","journal-title":"J Intern Med"},{"issue":"1","key":"5634_CR142","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14201","volume":"21","author":"L VandeVrede","year":"2025","unstructured":"VandeVrede L, Schindler SE (2025) Clinical use of biomarkers in the era of Alzheimer\u2019s disease treatments. Alzheimers Dement 21(1):e14201","journal-title":"Alzheimers Dement"},{"issue":"3","key":"5634_CR143","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonaitis E et al (2024) Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for alzheimer disease pathology. JAMA Neurol 81(3):255\u2013263","journal-title":"JAMA Neurol"},{"issue":"7","key":"5634_CR144","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41582-024-00977-5","volume":"20","author":"SE Schindler","year":"2024","unstructured":"Schindler SE, Galasko D, Pereira AC, Rabinovici GD, Salloway S, Su\u00e1rez-Calvet M et al (2024) Acceptable performance of blood biomarker tests of amyloid pathology \u2014 recommendations from the Global CEO Initiative on Alzheimer\u2019s disease. Nat Rev Neurol 20(7):426\u2013439","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"5634_CR145","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1093\/brain\/awaf003","volume":"148","author":"A Delva","year":"2025","unstructured":"Delva A, Pelletier A, Somerville E, Montplaisir J, Gagnon JF, Kollmorgen G et al (2025) Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder. Brain 148(6):2049\u20132059","journal-title":"Brain"},{"key":"5634_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071713","author":"Y Ma","year":"2022","unstructured":"Ma Y, Brettschneider J, Collingwood JF (2022) A systematic review and meta-analysis of cerebrospinal fluid amyloid and tau levels identifies mild cognitive impairment patients progressing to Alzheimer\u2019s disease. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10071713","journal-title":"Biomedicines"},{"key":"5634_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136271","author":"HM Yang","year":"2025","unstructured":"Yang HM (2025) Recent advances in antibody therapy for Alzheimer\u2019s disease: focus on bispecific antibodies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26136271","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5634_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100569","volume":"22","author":"AD Barker","year":"2023","unstructured":"Barker AD, Alba MM, Mallick P, Agus DB, Lee JSH (2023) An inflection point in cancer protein biomarkers: what was and what\u2019s next. Mol Cell Proteomics 22(7):100569","journal-title":"Mol Cell Proteomics"},{"issue":"3","key":"5634_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70050","volume":"21","author":"P Reho","year":"2025","unstructured":"Reho P, Kalia V, Jackson GL, Wang F, Eiten E, Brennan K et al (2025) Preclinical Alzheimer\u2019s disease shows alterations in circulating neuronal-derived extracellular vesicle microRNAs in a multiethnic cohort. Alzheimers Dement 21(3):e70050","journal-title":"Alzheimers Dement"},{"key":"5634_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13060602","author":"LB Cham","year":"2025","unstructured":"Cham LB, Hamdan TA, Bhat H, Sirajo B, Ali M, Tabbara KS et al (2025) Immunotherapeutic blockade of CD47 increases virus neutralization antibodies. Vaccines. https:\/\/doi.org\/10.3390\/vaccines13060602","journal-title":"Vaccines"},{"issue":"11","key":"5634_CR151","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","volume":"78","author":"S Janelidze","year":"2021","unstructured":"Janelidze S, Teunissen CE, Zetterberg H, Allu\u00e9 JA, Sarasa L, Eichenlaub U et al (2021) Head-to-head comparison of 8 plasma amyloid-\u03b2 42\/40 assays in Alzheimer disease. JAMA Neurol 78(11):1375\u20131382","journal-title":"JAMA Neurol"},{"issue":"8","key":"5634_CR152","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E et al (2020) Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA 324(8):772\u2013781","journal-title":"JAMA"},{"issue":"1","key":"5634_CR153","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70080","volume":"17","author":"AH Dyer","year":"2025","unstructured":"Dyer AH, Dunne J, Dolphin H, Morrison L, O\u2019Connor A, Fullam S et al (2025) Clinical performance of the fully automated Lumipulse plasma p-tau217 assay in mild cognitive impairment and mild dementia. Alzheimers Dement (Amst) 17(1):e70080","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"5634_CR154","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2217\/bmm.09.84","volume":"4","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty M, Lovestone S (2010) Blood-based biomarkers of Alzheimer\u2019s disease: challenging but feasible. Biomark Med 4(1):65\u201379","journal-title":"Biomark Med"},{"issue":"1","key":"5634_CR155","volume":"13","author":"MR Campbell","year":"2021","unstructured":"Campbell MR, Ashrafzadeh-Kian S, Petersen RC, Mielke MM, Syrjanen JA, van Harten AC et al (2021) P\u2010tau\/A\u03b242 and A\u03b242\/40 ratios in CSF are equally predictive of amyloid PET status. Alzheimers Dement Diagn Assess Dis Monit 13(1):e12190","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"issue":"12","key":"5634_CR156","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1158\/2159-8290.CD-21-0634","volume":"11","author":"EJ Moding","year":"2021","unstructured":"Moding EJ, Nabet BY, Alizadeh AA, Diehn M (2021) Detecting liquid remnants of solid tumors: circulating tumor DNA minimal residual disease. Cancer Discov 11(12):2968\u20132986","journal-title":"Cancer Discov"},{"key":"5634_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8050651","author":"K Govindpani","year":"2019","unstructured":"Govindpani K, McNamara LG, Smith NR, Vinnakota C, Waldvogel HJ, Faull RL et al (2019) Vascular dysfunction in Alzheimer\u2019s disease: a prelude to the pathological process or a consequence of it? J Clin Med. https:\/\/doi.org\/10.3390\/jcm8050651","journal-title":"J Clin Med"},{"issue":"1","key":"5634_CR158","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1186\/s12967-025-07327-z","volume":"23","author":"GJ Mart\u00ed-Chill\u00f3n","year":"2025","unstructured":"Mart\u00ed-Chill\u00f3n GJ, Munti\u00f3n S, Flores-Montero J, Gonz\u00e1lez-Robledo J, Corchete L, Pozo J et al (2025) Immune cell dynamics, cytokines, and extracellular vesicles in systemic inflammatory response syndrome (SIRS): a multiparametric analysis. J Transl Med 23(1):1331","journal-title":"J Transl Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05634-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05634-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05634-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:02:44Z","timestamp":1767988964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05634-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":158,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5634"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05634-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"21 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"342"}}